Back to Screener

Thermo Fisher Scientific, Inc. (TMO)

Price$494.04
Value ScoreC
Growth ScoreD
Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-29.94%
Price vs S&P 500 (4W)-0.01%
VGM Score47.20
Market Capitalization$183.03B
P/E Ratio (Annual)27.31x
Indicated Dividend Yield (Annual)0.38%

All Metrics

P/CF (Annual)23.41x
Book Value / Share (Quarterly)$139.77
P/TBV (Annual)5.79x
Indicated Dividend (Annual)$1.88
Revenue Growth (3Y)-0.27%
Cash Flow / Share (Quarterly)$18.15
Payout Ratio (TTM)9.48%
Price vs S&P 500 (YTD)-25.94%
Gross Margin (TTM)40.89%
Net Profit Margin (TTM)15.15%
EPS (TTM)$18.17
10-Day Avg Trading Volume2.74M
EPS Excl Extra (TTM)$18.17
Revenue Growth (5Y)6.70%
EPS (Annual)$17.73
Dividend / Share (Annual)$1.68
ROI (Annual)7.22%
Gross Margin (Annual)40.93%
Net Profit Margin (5Y Avg)15.79%
Cash / Share (Quarterly)$8.76
P/E Basic Excl Extra (TTM)26.73x
Revenue Growth QoQ (YoY)6.18%
EPS Growth (5Y)2.11%
P/E Normalized (Annual)27.31x
ROA (Last FY)6.07%
Revenue Growth TTM (YoY)5.36%
EBITD / Share (TTM)$24.15
ROE (5Y Avg)14.58%
Operating Margin (TTM)17.46%
Cash Flow / Share (Annual)$16.73
P/B Ratio3.52x
P/B Ratio (Quarterly)3.43x
Net Income / Employee (Annual)$53,600
EV / Revenue (TTM)4.93x
Net Interest Coverage (TTM)18.69x
ROA (TTM)6.40%
EPS Growth QoQ (YoY)11.32%
EV / EBITDA (TTM)24.51x
EPS Incl Extra (Annual)$17.73
Current Ratio (Annual)1.89x
Quick Ratio (Quarterly)1.15x
3-Month Avg Trading Volume2.34M
52-Week Price Return21.98%
EV / Free Cash Flow (Annual)35.43x
P/E Incl Extra (TTM)26.73x
Revenue / Employee (TTM)$361,600
Tangible BV / Share (Quarterly)$88.25
P/S Ratio (Annual)4.11x
Asset Turnover (Annual)0.40x
52-Week High$643.99
Operating Margin (5Y Avg)18.55%
EPS Excl Extra (Annual)$17.73
CapEx CAGR (5Y)0.68%
Tangible BV CAGR (5Y)11.48%
26-Week Price Return-14.01%
Quick Ratio (Annual)1.53x
13-Week Price Return-5.31%
Total Debt / Equity (Annual)0.74x
Current Ratio (Quarterly)1.53x
Enterprise Value$222.93B
Revenue / Share Growth (5Y)7.86%
Asset Turnover (TTM)0.42x
Book Value / Share Growth (5Y)10.29%
Revenue / Employee (Annual)$356,400
Inventory Turnover (Annual)5.06x
Pretax Margin (Annual)16.40%
Cash / Share (Annual)$26.86
3-Month Return Std Dev35.06%
Gross Margin (5Y Avg)42.89%
Net Income / Employee (TTM)$54,800
EBITDA CAGR (5Y)0.80%
EBITDA Interim CAGR (5Y)-5.55%
ROE (Last FY)12.55%
Net Interest Coverage (Annual)18.02x
EPS Basic Excl Extra (Annual)$17.73
P/FCF (TTM)27.13x
Receivables Turnover (TTM)4.75x
EV / Free Cash Flow (TTM)33.05x
Total Debt / Equity (Quarterly)0.83x
EPS Incl Extra (TTM)$18.17
Receivables Turnover (Annual)4.41x
ROI (TTM)7.60%
Dividend Growth Rate (5Y)14.67%
P/S Ratio (TTM)4.05x
Pretax Margin (5Y Avg)17.50%
Revenue / Share (Annual)$117.87
Tangible BV / Share (Annual)$99.86
Forward P/E19.08x
Free OCF CAGR (5Y)-1.58%
Price vs S&P 500 (52W)-6.22%
P/E Ratio (TTM)26.73x
EPS Growth TTM (YoY)6.66%
Year-to-Date Return-15.00%
5-Day Price Return9.87%
EPS Normalized (Annual)$17.73
ROA (5Y Avg)6.78%
Net Profit Margin (Annual)15.04%
Month-to-Date Return2.83%
Cash Flow / Share (TTM)$24.23
EBITD / Share (Annual)$23.27
EPS Growth (3Y)0.18%
Operating Margin (Annual)17.38%
LT Debt / Equity (Annual)0.67x
P/CF (TTM)22.09x
ROI (5Y Avg)8.29%
P/E Excl Extra (TTM)26.73x
LT Debt / Equity (Quarterly)0.77x
EPS Basic Excl Extra (TTM)$18.17
P/TBV (Quarterly)5.44x
Payout Ratio (Annual)9.49%
P/B Ratio (Annual)4.08x
Dividend / Share (TTM)$1.73
Inventory Turnover (TTM)4.98x
Pretax Margin (TTM)16.42%
Book Value / Share (Annual)$141.96
Price vs S&P 500 (13W)-15.05%
Net Margin Growth (5Y)-5.34%
Dividend Yield (TTM)0.35%
Beta0.88x
P/FCF (Annual)29.08x
Revenue / Share (TTM)$121.17
ROE (TTM)13.24%
52-Week Low$385.46
vGradeC
gGradeD
mGradeC
vgmGradeC
Show chart for

Earnings Surprise History

Q1 265.44est. 5.29

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
4.09
4.15
4.20
4.21

Industry Peers — Measuring & Controlling Devices(10)

About

Thermo Fisher Scientific supplies scientific instruments, laboratory equipment, diagnostics, and life science reagents to pharmaceutical, biotech, clinical, and academic research markets. The company operates through four segments: analytical technologies, specialty diagnostics, life science solutions, and lab products and services, which includes contract research operations.